SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-016605
Filing Date
2024-05-14
Accepted
2024-05-14 16:01:59
Documents
48
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q govx20240331_10q.htm   iXBRL 10-Q 462654
2 EXHIBIT 3.1 ex_671452.htm EX-3.1 25028
3 EXHIBIT 31.1 ex_671453.htm EX-31.1 12419
4 EXHIBIT 31.2 ex_671454.htm EX-31.2 12466
5 EXHIBIT 32.1 ex_671455.htm EX-32.1 4357
6 EXHIBIT 32.2 ex_671456.htm EX-32.2 4375
  Complete submission text file 0001437749-24-016605.txt   2381329

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA govx-20240331.xsd EX-101.SCH 27114
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20240331_def.xml EX-101.DEF 159508
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20240331_lab.xml EX-101.LAB 146421
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20240331_pre.xml EX-101.PRE 177156
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE govx-20240331_cal.xml EX-101.CAL 20867
52 EXTRACTED XBRL INSTANCE DOCUMENT govx20240331_10q_htm.xml XML 224765
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

IRS No.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39563 | Film No.: 24944107
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)